Intellia Therapeutics Inc buy BenchmarkLong70
Start price
29.10.24
/
50%
€15.30
Target price
29.11.24
-
Performance (%)
-2.62%
End price
30.11.24
€14.90
Summary
This prediction ended on 30.11.24 with a price of €14.90. With a performance of -2.62%, the BUY prediction by BenchmarkLong70 finished with a loss. BenchmarkLong70 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 4.443% | 4.443% | 38.474% |
| iShares Core DAX® | -3,81 % | -1,47 % | 6,06 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % | 12,68 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % | 30,91 % |
| iShares S&P 500 | 0,25 % | 1,23 % | 9,37 % |
Comments by BenchmarkLong70 for this prediction
In the thread Trading Intellia Therapeutics Inc
Die von BenchmarkLong70 gewählte maximale Laufzeit wurde überschritten